Viewing Study NCT04439292


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-25 @ 2:01 PM
Study NCT ID: NCT04439292
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2020-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module